Optimal Management of Status Epilepticus in Children in the Emergency Setting: A Review of Recent Advances

References

• Trinka E, Kälviäinen R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017;44:65–73. doi:10.1016/j.seizure.2016.11.001
   PubMed Web of Science ®Google Scholar
• Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus - report of the ILAE Task force on classification of status epilepticus. Epilepsia. 2015;56:1515–1523. doi:10.1111/epi.13121
   PubMed Web of Science ®Google Scholar
• Shinnar S, Berg AT, Moshe SL, Shinnar R. How long do new-onset seizures in children last? Ann Neurol. 2001;5:659–664. doi:10.1002/ana.1018
   Web of Science ®Google Scholar
• Eriksson K, Metsaranta P, Huhtala H, Auvinen A, Kuusela A-L, Koivikko M. Treatment delay and the risk of prolonged status epilepticus. Neurology. 2005;65:1316–1318. doi:10.1212/01.wnl.0000180959.31355.92
   PubMed Web of Science ®Google Scholar
• Sahin M, Menache CC, Holmes GL, Riviello JJ. Outcome of severe refractory status epilepticus in children. Epilepsia. 2001;42:1461–1467. doi:10.1046/j.1528-1157.2001.21301.x
   PubMed Web of Science ®Google Scholar
• Chin RF, Neville BG, Peckham C, Bedford H, Wade A, Scott RC; NLSTEPSS Collaborative Group. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006;368:222–229. doi:10.1016/S0140-6736(06)69043-0
   PubMed Web of Science ®Google Scholar
• Novorol CL, Chin RF, Scott RC. Outcome of convulsive status epilepticus: a review. Arch Dis Child. 2007;92:948–951. doi:10.1136/adc.2006.107516
   PubMed Web of Science ®Google Scholar
• Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11:800–810. doi:10.1111/j.1468-1331.2004.00943.x
   PubMed Web of Science ®Google Scholar
• Mitchell C, Chatterton Dickson L, Ramsay A, et al. Epidemiology and outcome of status epilepticus in children: a Scottish population cohort study. Dev Med Child Neurol. 2021;63:1075–1084. doi:10.1111/dmcn.14900
   PubMed Web of Science ®Google Scholar
• Kapur J, Elm J, Chamberlain JM, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381:2103–2113. doi:10.1056/NEJMoa1905795
   PubMed Web of Science ®Google Scholar
• Trinka E, Höfler J, Zerbs A. Causes of status epilepticus. Epilepsia. 2012;53(Suppl 4):S127–S138. doi:10.1111/j.1528-1167.2012.03622.x
   PubMed Web of Science ®Google Scholar
• Vasquez A, Gaínza-Lein M, Sánchez Fernández I, et al. Pediatric Status Epilepticus Research Group (pSERG). Hospital emergency treatment of convulsive status epilepticus: comparison of pathways from ten pediatric research centers. Pediatr Neurol. 2018;86:33–41. doi:10.1016/j.pediatrneurol.2018.06.004
   PubMed Web of Science ®Google Scholar
• Advanced Paediatric life support: a practical approach to emergencies (APLS) 6th Edition; 2022. Available from: http://www.alsg.org/uk/Publications. Accessed April 20, 2022.
   Google Scholar
• Resuscitation Council UK. Paediatric emergency algorithms and resources; 2022. Available from: https://www.resus.org.uk/sites/default/files/2022-03/RCUK%20Paediatric%20emergency%20algorithms%20and%20resources%20Mar%2022%20V1.pdf. Accessed April 20, 2022.
   Google Scholar
• McTague A, Martland T, Appleton R. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev. 2018;1:CD001905. doi:10.1002/14651858.CD001905.pub3
   PubMed Web of Science ®Google Scholar
• Singh A, Stredny CM, Loddenkemper T. Pharmacotherapy for paediatric convulsive status epilepticus. CNS Drugs. 2020;34:47–63. doi:10.1007/s40263-019-00690-8
   PubMed Web of Science ®Google Scholar
• Zhao Z, Wang H, Wen B, Yang Z, Feng K, Fan J. A comparison of midazolam, lorazepam, and diazepam for the treatment of status epilepticus in children: a network meta-analysis. J Child Neurol. 2016;31:1093–1107. doi:10.1177/0883073816638757
   PubMed Web of Science ®Google Scholar
• McKenzie KC, Hahn CD, Friedman JN. Emergency management of the paediatric patient with convulsive status epilepticus. Paediatr Child Health. 2021;26:50–57. doi:10.1093/pch/pxaa127
   PubMed Web of Science ®Google Scholar
• Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr. 2016;16:48–61. doi:10.5698/1535-7597-16.1.48
   PubMed Web of Science ®Google Scholar
• Lane RD, Schunk JE. Atomised intranasal midazolam use for minor procedures in the pediatric emergency department. Pediatr Emerg Care. 2008;24:300–303. doi:10.1097/PEC.0b013e31816ecb6f
   PubMed Web of Science ®Google Scholar
• European Medicines Agency 2022. EMA recommends authorisation of Nasolam (midazolam, nasal spray) in the EU 28/01/2022; 2022. Available from: https://www.ema.europa.eu/en/documents/referral/nasolam-article-294-referral-ema-recommends-authorisation-nasolam-midazolam-nasal-spray-eu_en.pdf. Accessed April 20, 2022.
   Google Scholar
• Alansari K, Barkat M, Mohamed AH, et al. Intramuscular versus buccal midazolam for pediatric seizures: a randomized double-blinded trial. Pediatr Neurol. 2020;109:28–34. doi:10.1016/j.pediatrneurol.2020.03.011
   PubMed Web of Science ®Google Scholar
• Arya R, Gulati S, Kabra M, Sahu JK, Kalra V. Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study. Epilepsia. 2011;52:788–793. doi:10.1111/j.1528-1167.2010.02949.x
   PubMed Web of Science ®Google Scholar
• Epilepsy Foundation. Diazepam Nasal; 2022. Available from: https://www.epilepsy.com/tools-resources/seizure-medication-list/diazepam-nasal. Accessed April 20, 2022.
   Google Scholar
• Brigo F, Nardone R, Tezzon F, Trinka E. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: a systematic review with meta-analysis. Epilepsy Behav. 2015;49:325–336. doi:10.1016/j.yebeh.2015.02.030
   PubMed Web of Science ®Google Scholar
• Chamberlain JM, Okada P, Holsti M, et al. Pediatric Emergency Care Applied Research Network (PECARN). Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA. 2014;311:1652–1660. doi:10.1001/jama.2014.2625
   PubMed Web of Science ®Google Scholar
• Shorvon S. Antiepileptic drugs: paraldehyde. In: Shorvon S, editor. Status Epilepticus: Its Clinical Features and Treatment in Children and Adults. Cambridge: Cambridge University Press; 1994:218–223.
   Google Scholar
• Ahmad S, Ellis JC, Kamwendo H, Molyneux E. Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial. Lancet. 2006;367:1591–1597. doi:10.1016/S0140-6736(06)68696-0
   PubMed Web of Science ®Google Scholar
• Rowland AG, Gill AM, Stewart AB, et al. Review of the efficacy of rectal paraldehyde in the management of acute and prolonged tonic-clonic convulsions. Arch Dis Child. 2009;94:720–723. doi:10.1136/adc.2009.157636
   PubMed Web of Science ®Google Scholar
• Chin RF, Verhulst L, Neville BG, Peters MJ, Scott RC. Inappropriate emergency management of status epilepticus in children contributes to need for intensive care. J Neurol Neurosurg Psychiatry. 2004;75:1584–1588. doi:10.1136/jnnp.2003.032797
   PubMed Web of Science ®Google Scholar
• Shorvon S. Antiepileptic drugs: phenobarbitone (phenobarbital). In: Shorvon S, editor. Status Epilepticus: Its Clinical Features and Treatment in Children and Adults. Cambridge: Cambridge University Press; 1994:254–261.
   Google Scholar
• Lowenstein DH. Treatment options for status epilepticus. Curr Opin Pharmacol. 2005;5:334–339. doi:10.1016/j.coph.2005.04.003
   PubMed Web of Science ®Google Scholar
• Burman RJ, Ackermann S, Shapson-Coe A, Ndondo A, Buys H, Wilmshurst JM. A comparison of parenteral phenobarbital vs. parenteral phenytoin as second-line management for pediatric convulsive status epilepticus in a resource-limited setting. Front Neurol. 2019;10:506. doi:10.3389/fneur.2019.00506
   PubMed Web of Science ®Google Scholar
• Wirrell EC. Treatment of Dravet syndrome. Can J Neurol Sci. 2016;43(Suppl 3):S13–S18. doi:10.1017/cjn.2016.249
   PubMed Web of Science ®Google Scholar
• Tanabe T, Awaya Y, Matsuishi T, et al. Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome) – a nationwide questionnaire survey in Japan. Brain Dev. 2008;30:629–635. doi:10.1016/j.braindev.2008.03.002
   PubMed Web of Science ®Google Scholar
• Su Y, Liu G, Tian F, et al. Phenobarbital versus valproate for generalized convulsive status epilepticus in adults: a prospective randomized controlled trial in China. CNS Drugs. 2016;30:1201–1207. doi:10.1007/s40263-016-0388-6
   PubMed Web of Science ®Google Scholar
• Lewena S, Pennington V, Acworth J, et al. Emergency management of pediatric convulsive status epilepticus: a multicenter study of 542 patients. Pediatr Emerg Care. 2009;25:83–87. doi:10.1097/PEC.0b013e318196ea6e
   PubMed Web of Science ®Google Scholar
• Pujar S, Scott RC. Levetiracetam for treatment of convulsive status epilepticus: time to update childhood convulsive status epilepticus treatment guidelines? Arch Dis Child. 2021;106:418–419. doi:10.1136/archdischild-2020-321033
   Web of Science ®Google Scholar
• Singh K, Aggarwal A, Faridi M, Sharma S. IV levetiracetam versus IV phenytoin in childhood seizures: a randomized controlled trial. J Pediatr Neurosci. 2018;13:158–164. doi:10.4103/JPN.JPN_126_17
   PubMed Web of Science ®Google Scholar
• Appleton RE, Gill A. Adverse events associated with intravenous phenytoin in children: a prospective study. Seizure. 2003;12:369–372. doi:10.1016/S1059-1311(02)00338-2
   PubMed Web of Science ®Google Scholar
• Eriksson K, Keränen T, Kälviäinen R. Fosphenytoin. Expert Opin Drug Metab Toxicol. 2009;5:695–701. doi:10.1517/17425250902997975
   PubMed Web of Science ®Google Scholar
• Lyttle MD, Rainford NEA, Gamble C, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre open-label, randomised trial. Lancet. 2019;393:2125–2134. doi:10.1016/S0140-6736(19)30724-X
   PubMed Web of Science ®Google Scholar
• Dalziel SR, Borland ML, Furyk J, et al. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial. Lancet. 2019;393:2135–2145. doi:10.1016/S0140-6736(19)30722-6
   PubMed Web of Science ®Google Scholar
• Chamberlain JM, Kapur J, Shinnar S, et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double blind, response -adaptive, randomised controlled trial. Lancet. 2020;395:1217–1224. doi:10.1016/S0140-6736(20)30611-5
   PubMed Web of Science ®Google Scholar
• Trinka E, Höfler J, Zerbs A, Brigo F. Efficacy and safety of intravenous valproate for status epilepticus: a systematic review. CNS Drugs. 2014;28:623–639. doi:10.1007/s40263-014-0167-1
   PubMed Web of Science ®Google Scholar
• Abdelgadir I, Hamud A, Kadri A, et al. Levetiracetam for convulsive status epilepticus in childhood: systematic review and meta-analysis. Arch Dis Child. 2020;106:470–476. doi:10.1136/archdischild-2020-319573
   Web of Science ®Google Scholar
• Feng Y, Chen Y, Jia Y, et al. Efficacy and safety of levetiracetam versus (fos) phenytoin for second-line treatment of epilepticus: a meta-analysis of latest randomized controlled trials. Seizure. 2021;91:339–345. doi:10.1016/j.seizure.2021.07.012
   PubMed Web of Science ®Google Scholar
• Poddar K, Sharma R, Ng YT. Intravenous lacosamide in pediatric status epilepticus: an open-label efficacy and safety study. Pediatr Neurol. 2016;61:83–86. doi:10.1016/j.pediatrneurol.2016.03.021
   PubMed Web of Science ®Google Scholar
• Strzelczyk A, Zöllner JP, Willems LM, et al. Lacosamide in status epilepticus: systematic review of current evidence. Epilepsia. 2017;58:933–950. doi:10.1111/epi.13716
   PubMed Web of Science ®Google Scholar
• Panda PK, Panda P, Dawman L, Sharawat IK. Efficacy of lacosamide and phenytoin in status epilepticus: a systematic review. Acta Neurol Scand. 2021;144:366–374. doi:10.1111/ane.13469
   PubMed Web of Science ®Google Scholar
• Neligan A, Rajakulendran R, Walker MC. Advances in the management of generalized convulsive status epilepticus: what have we learned? Brain. 2021;144:1336–1341. doi:10.1093/brain/awab049
   PubMed Web of Science ®Google Scholar
• NICE Guideline (NG217). Epilepsies in children, young people and adults; 2022. Available from: https://www.nice.org.uk/guidance/ng217/chapter/5-Treating-epileptic-seizures-in-children-young-people-and-adults#focal-seizures-with-or-without-evolution-to-bilateral-tonic-clonic-seizures. Accessed June 24, 2022.
   Google Scholar
• McGinnis E, Kessler SK. Lacosamide use in children with epilepsy: retention rate and effect of concomitant sodium channel blockers in a large cohort. Epilepsia. 2016;57:1416–1425. doi:10.1111/epi.13466
   PubMed Web of Science ®Google Scholar
• Suzuki T, Natsume J, Kumai S, et al. Effectiveness of lacosamide in children and young adults previously treated with other sodium channel blockers. Epilepsy Behav. 2021;125:108397. doi:10.1016/j.yebeh.2021.108397
   PubMed Web of Science ®Google Scholar
• Nakamura K, Inokuchi R, Daidoji H, et al. Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus. Medicine. 2017;96:e7206. doi:10.1097/MD.0000000000007206
   PubMed Web of Science ®Google Scholar
• Sánchez Fernández I, Gaínza-Lein M, Lamb N, Loddenkemper T. Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. Neurology. 2019;92:e2339–48. doi:10.1212/WNL.0000000000007503
   PubMed Web of Science ®Google Scholar
• Braun J, Gau E, Revelle S, et al. Impact of non-guideline-based treatment of status epilepticus. J Neurol Sci. 2017;382:126–130. doi:10.1016/j.jns.2017.09.031
   PubMed Web of Science ®Google Scholar
• Rao SK, Mahulikar A, Ibrahim M, et al. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus. Epileptic Disord. 2018;20:265–269. doi:10.1684/epd.2018.0987
   PubMed Web of Science ®Google Scholar
• Sathe AG, Underwood E, Coles LD, et al. Patterns of benzodiazepine underdosing in the established status epilepticus treatment trial. Epilepsia. 2021;62:795–806. doi:10.1111/epi.16825
   PubMed Web of Science ®Google Scholar
• Stewart WA, Harrison R, Dooley JM. Respiratory depression in the acute management of seizures. Arch Dis Child. 2002;87:225–226. doi:10.1136/adc.87.3.225
   PubMed Web of Science ®Google Scholar
• Sánchez Fernández I, Abend NS, Amengual-Gual M, et al. pSERG. Association of guideline publication and delays to treatment in pediatric status epilepticus. Neurology. 2020;95:e1222–e1235. doi:10.1212/WNL.0000000000010174
   PubMed Web of Science ®Google Scholar
• Keene JC, Woods B, Wainwright M, King M, Morgan LA. Optimized benzodiazepine treatment of pediatric status epilepticus through a standardized emergency medical services resuscitation tool. Pediatr Neurol. 2022;126:50–55. doi:10.1016/j.pediatrneurol.2021.10.001
   PubMed Web of Science ®Google Scholar
• Zaccara G, Giorgi FS, Amantini A, et al. Why we prefer levetiracetam over phenytoin for treatment of status epilepticus. Acta Neurol Scand. 2018;137:618–622. doi:10.1111/ane.12928
   PubMed Web of Science ®Google Scholar
• Kellinghaus C, Rossetti AO, Trinka E, et al. Factors predicting cessation of status epilepticus in clinical practice: data from a prospective observational registry (SENSE). Ann Neurol. 2019;85:421–432. doi:10.1002/ana.25416
   PubMed Web of Science ®Google Scholar
• Alvarez V, Lee JW, Drislane FW, et al. Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: a multicenter comparison. Epilepsia. 2015;56:1275–1285. doi:10.1111/epi.13056
   PubMed Web of Science ®Google Scholar
• Trau SP, Sterrett EC, Feinstein L, et al. Institutional pediatric convulsive status epilepticus protocol decreases time to first and second line anti-seizure medication administration. Seizure. 2020;81:263–268. doi:10.1016/j.seizure.2020.08.011
   PubMed Web of Science ®Google Scholar
• Guterman EL, Sanford JK, Betjemann JP, et al. Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus. Neurology. 2020;95:e3203–12. doi:10.1212/WNL.0000000000010913
   PubMed Web of Science ®Google Scholar
• Misra UK, Kalita J, Maurya PK. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J Neurol. 2012;259:645–648. doi:10.1007/s00415-011-6227-2
   PubMed Web of Science ®Google Scholar